Corporate Communications Manager |
Madrid Delegación |
Espagne |
Corporate Affairs |
CTS |
Communications & Public Affairs |
nov 21, 2024 |
Corporate Communications Manager |
London (The Westworks) |
Royaume-Uni de Grande-Bretagne et d'Irl. du Nord |
Corporate Affairs |
CTS |
Communications & Public Affairs |
nov 21, 2024 |
Associate Director, Patient Engagement, Neuroscience and Gene Therapies |
East Hanover |
Etats-Unis |
Development |
Innovative Medicines |
Communications & Public Affairs |
nov 20, 2024 |
Manager, Corporate Marketing Creative & Design |
Basel (City) |
Suisse |
Corporate Affairs |
CTS |
Communications & Public Affairs |
nov 19, 2024 |
Senior Communications & Patient Advocacy Manager |
Bogota (Pharmaceuticals / GDD / NTO / CTS) |
Colombie |
Corporate Affairs |
CTS |
Communications & Public Affairs |
nov 19, 2024 |
Therapy Area Communications & Patient Advocacy Manager |
Barcelona Gran Vía |
Espagne |
Corporate Affairs |
CTS |
Communications & Public Affairs |
nov 14, 2024 |
Therapy Area Communications & Patient Advocacy & Disease Agnostic Lead, Spain |
Barcelona Gran Vía |
Espagne |
Corporate Affairs |
CTS |
Communications & Public Affairs |
nov 14, 2024 |
Vice President of European Public Affairs |
Vilvoorde |
Belgique |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
nov 14, 2024 |
Communications & Patient Advocacy Sr. Specialist (1 yr contract) |
Seoul |
République de Corée |
Corporate Affairs |
CTS |
Communications & Public Affairs |
nov 13, 2024 |
Senior Manager, Site Communications Basel |
Basel (City) |
Suisse |
Corporate Affairs |
CTS |
Communications & Public Affairs |
nov 11, 2024 |
Director, Issue Advocacy & Portfolio Strategy |
Washington, DC |
Etats-Unis |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
nov 11, 2024 |
Associate Director, Issue Advocacy & Strategic Alliances |
Washington, DC |
Etats-Unis |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
nov 11, 2024 |
Directeur Affaires Publiques Aire Thérapeutique H/F |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
International |
Innovative Medicines |
Communications & Public Affairs |
nov 08, 2024 |
Director of Policy Communications and Media Relations, Europe |
Basel (City) |
Suisse |
Corporate Affairs |
CTS |
Communications & Public Affairs |
nov 07, 2024 |
Communications & Patient Advocacy Manager |
Selangor |
Malaisie |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
nov 06, 2024 |
Lead - Government Affairs |
Delhi (Office) |
Inde |
International |
Innovative Medicines |
Communications & Public Affairs |
nov 05, 2024 |
Executive Director, Therapy Area Communications and Patient Advocacy |
Basel (City) |
Suisse |
Corporate Affairs |
CTS |
Communications & Public Affairs |
nov 04, 2024 |
Communication & Patient Advocacy Manager (f/m/d) |
Vienna |
Autriche |
International |
CTS |
Communications & Public Affairs |
oct 31, 2024 |
Associate Director, Business Transformation & Engagement |
Barcelona Gran Vía |
Espagne |
Development |
Innovative Medicines |
Communications & Public Affairs |
oct 23, 2024 |
Government Affairs Manager |
Moscow (City) |
Féd. de Russie |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
oct 22, 2024 |
(Sr.) Public Affairs Manager |
Taipei |
Taiwan |
International |
Innovative Medicines |
Communications & Public Affairs |
oct 20, 2024 |
Comms & Engagement Manager |
Amsterdam |
Pays-Bas |
Corporate Affairs |
CTS |
Communications & Public Affairs |
oct 16, 2024 |
Associate Director, R&D Portfolio and Engagement - Communications |
Cambridge (Massachusetts) |
Etats-Unis |
Corporate Affairs |
CTS |
Communications & Public Affairs |
oct 08, 2024 |
Public Affairs Manager |
Ankara Gimat |
Turquie |
International |
Innovative Medicines |
Communications & Public Affairs |
Sep 13, 2024 |
Patient Engagement Lead |
İstanbul Kavacık |
Turquie |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Sep 03, 2024 |
Public Affairs Manager (m/f/d) |
Berlin West (Non-Sales Force) (Novartis Pharma GmbH) |
Allemagne |
International |
Innovative Medicines |
Communications & Public Affairs |
Juil 09, 2024 |